RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea
2014-01-01 Verstovsek, S; Passamonti, Francesco; Rambaldi, A; Barosi, G; Rosen, Pj; Rumi, Elisa; Gattoni, E; Pieri, L; Guglielmelli, P; Elena, Chiara; He, S; Contel, N; Mookerjee, B; Sandor, V; Cazzola, Mario; Kantarjian, Hm; Barbui, T; Vannucchi, A. M.
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes
2007-01-01 DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca; Travaglino, E; Pascutto, C; Maffioli, M; Invernizzi, Rosangela; Cazzola, Mario
A prognostic model to predict survival in 867 WHO-defined essential thrombocythemia at diagnosis: a study by the IWG-MRT.
2012-01-01 Passamonti, F; Thiele, J; Girodon, F; Rumi, Elisa; Carobbio, A; Gisslinger, H; Kvasnicka, Hm; Ruggeri, M; Randi, Ml; Gangat, N; Vannucchi, Am; Gianatti, A; Gisslinger, B; Müllauer, L; Rodeghiero, F; D'Amore, Es; Bertozzi, I; Hanson, Ca; Boveri, E; Marino, F; Maffioli, M; Caramazza, D; Antonioli, E; Carrai, V; Buxhofer Ausch, V; Pascutto, C; Cazzola, Mario; Barbui, T; Tefferi, A.
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
2010-01-01 Passamonti, Francesco; Rumi, Elisa; Pietra, D; Elena, Chiara; Boveri, E; Arcaini, Luca; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, Mario; Cazzola, Mario
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
2011-01-01 Fenaux, P; Giagounidis, A; Selleslag, D; Beyne Rauzy, O; Mufti, G; Mittelman, M; Muus, P; Te Boekhorst, P; Sanz, G; Del Cañizo, C; Guerci Bresler, A; Nilsson, L; Platzbecker, U; Lübbert, M; Quesnel, B; Cazzola, Mario; Ganser, A; Bowen, D; Schlegelberger, B; Aul, C; Knight, R; Francis, J; Fu, T; Hellström Lindberg, E; MDS 004 Lenalidomide del5q Study, Group
A rare lymphoma with skin involvement
2004-01-01 Invernizzi, Rosangela; Cazzola, Mario
A relapsing fever
2004-01-01 Invernizzi, Rosangela; Cazzola, Mario
A screen for RAS mutations in individuals at risk of secondary leukaemia due to occupational exposure to petrochemicals.
1995-01-01 Taylor, C; Hughes, Dc; Zappone, E; Cazzola, Mario; Carter, G; Jacobs, A; Padua, Ra
A translational link between Fe and Epo
2013-01-01 Cazzola, Mario
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes
2005-01-01 Malcovati, Luca; Germing, U; Kuendgen, A; DELLA PORTA, MATTEO GIOVANNI; Invernizzi, Rosangela; Giagounidis, A; Hildebrandt, B; Bernasconi, Paolo; Knipp, S; Lazzarino, Mario; Strupp, C; Cazzola, Mario
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea | 1-gen-2014 | Verstovsek, S; Passamonti, Francesco; Rambaldi, A; Barosi, G; Rosen, Pj; Rumi, Elisa; Gattoni, E; Pieri, L; Guglielmelli, P; Elena, Chiara; He, S; Contel, N; Mookerjee, B; Sandor, V; Cazzola, Mario; Kantarjian, Hm; Barbui, T; Vannucchi, A. M. | |
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes | 1-gen-2007 | DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca; Travaglino, E; Pascutto, C; Maffioli, M; Invernizzi, Rosangela; Cazzola, Mario | |
A prognostic model to predict survival in 867 WHO-defined essential thrombocythemia at diagnosis: a study by the IWG-MRT. | 1-gen-2012 | Passamonti, F; Thiele, J; Girodon, F; Rumi, Elisa; Carobbio, A; Gisslinger, H; Kvasnicka, Hm; Ruggeri, M; Randi, Ml; Gangat, N; Vannucchi, Am; Gianatti, A; Gisslinger, B; Müllauer, L; Rodeghiero, F; D'Amore, Es; Bertozzi, I; Hanson, Ca; Boveri, E; Marino, F; Maffioli, M; Caramazza, D; Antonioli, E; Carrai, V; Buxhofer Ausch, V; Pascutto, C; Cazzola, Mario; Barbui, T; Tefferi, A. | |
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. | 1-gen-2010 | Passamonti, Francesco; Rumi, Elisa; Pietra, D; Elena, Chiara; Boveri, E; Arcaini, Luca; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, Mario; Cazzola, Mario | |
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q | 1-gen-2011 | Fenaux, P; Giagounidis, A; Selleslag, D; Beyne Rauzy, O; Mufti, G; Mittelman, M; Muus, P; Te Boekhorst, P; Sanz, G; Del Cañizo, C; Guerci Bresler, A; Nilsson, L; Platzbecker, U; Lübbert, M; Quesnel, B; Cazzola, Mario; Ganser, A; Bowen, D; Schlegelberger, B; Aul, C; Knight, R; Francis, J; Fu, T; Hellström Lindberg, E; MDS 004 Lenalidomide del5q Study, Group | |
A rare lymphoma with skin involvement | 1-gen-2004 | Invernizzi, Rosangela; Cazzola, Mario | |
A relapsing fever | 1-gen-2004 | Invernizzi, Rosangela; Cazzola, Mario | |
A screen for RAS mutations in individuals at risk of secondary leukaemia due to occupational exposure to petrochemicals. | 1-gen-1995 | Taylor, C; Hughes, Dc; Zappone, E; Cazzola, Mario; Carter, G; Jacobs, A; Padua, Ra | |
A translational link between Fe and Epo | 1-gen-2013 | Cazzola, Mario | |
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes | 1-gen-2005 | Malcovati, Luca; Germing, U; Kuendgen, A; DELLA PORTA, MATTEO GIOVANNI; Invernizzi, Rosangela; Giagounidis, A; Hildebrandt, B; Bernasconi, Paolo; Knipp, S; Lazzarino, Mario; Strupp, C; Cazzola, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 480
- 1 Contributo su Rivista::1.1 Arti... 466
- 1 Contributo su Rivista::1.5 Abst... 14
Data di pubblicazione
- 2020 - 2023 23
- 2010 - 2019 170
- 2000 - 2009 127
- 1990 - 1999 77
- 1980 - 1989 73
- 1974 - 1979 10
Editore
- Macmillan Magazines Limited:Porte... 4
- Blackwell Science Limited:PO Box ... 3
- American Society of Hematology:19... 2
- American Society for Biochemistry... 1
- Elsevier Science Incorporated / N... 1
- John Wiley & Sons Incorporated:Cu... 1
- Marcel Dekker Incorporated:270 Ma... 1
Rivista
- HAEMATOLOGICA 103
- BLOOD 95
- BRITISH JOURNAL OF HAEMATOLOGY 54
- LEUKEMIA 35
- AMERICAN JOURNAL OF HEMATOLOGY 17
- AMERICAN JOURNAL OF HEMATOLOGY 11
- JOURNAL OF CLINICAL ONCOLOGY 10
- SCANDINAVIAN JOURNAL OF HAEMATOLOGY 9
- THE NEW ENGLAND JOURNAL OF MEDICINE 9
- HEMATOLOGY 6
Keyword
- Myelodysplastic syndrome 60
- Anemia 45
- Iron 31
- Myeloproliferative neoplasm 28
- JAK2 22
- prognosis 19
- Erythropoietin 18
- Erythropoiesis 17
- mutation 17
- MYELODYSPLASTIC SYNDROME 17
Lingua
- eng 474
- ita 2
- spa 1
Accesso al fulltext
- no fulltext 480